Stay updated on Niraparib Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedA notice about NIH’s terminology transition appears above the page, which still displays a 403 error rather than clinical trial information.SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and blocking access to the study details.SummaryDifference18%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, indicating a new version of the study page has been published. This reflects a maintenance/refresh of the page rather than changes to the trial details or results.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, indicating a minor backend/content update. No study content or key information was modified.SummaryDifference0.0%

Stay in the know with updates to Niraparib Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Maintenance in Advanced Ovarian Cancer Clinical Trial page.